Shingo Nakatani

Combination of Non-natural <scp>d</scp>-Amino Acid Derivatives and Allophenylnorstatine−Dimethylthioproline Scaffold in HIV Protease Inhibitors Have High Efficacy in Mutant HIV

Shingo Nakatani, Koushi Hidaka, Ei’ichi Ami et al. · Journal of Medicinal Chemistry · 2008 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and antiviral property of allophenylnorstatine-based HIV protease inhibitors incorporating d-cysteine derivatives as P2/P3 moieties

Ei’ichi Ami, Koichiro Nakahara, Akihiko Sato et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model

Yuzo Iwaki, Akira Ohhata, Shingo Nakatani et al. · ACS Medicinal Chemistry Letters · 2020 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Novel matrix metalloproteinase inhibitors: Generation of lead compounds by the in silico fragment-based approach

Kanji Takahashi, Masahiro Ikura, Hiromu Habashita et al. · Bioorganic & Medicinal Chemistry · 2005 · 25 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

Design and synthesis of novel metalloproteinase inhibitors

Shingo Nakatani, Masahiro Ikura, Shingo Yamamoto et al. · Bioorganic & Medicinal Chemistry · 2006 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12